| Anindya Kumar Sen, MD FACP | |
|
1406 Tusculum Blvd, Suite 2000, Greeneville, TN 37745-4332 | |
| (423) 787-7080 | |
| (423) 787-7087 |
| Full Name | Anindya Kumar Sen |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 52 Years |
| Location | 1406 Tusculum Blvd, Greeneville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518062652 | NPI | - | NPPES |
| 21891 | Other | TN | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 21891 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Greeneville Community Hospital | Greeneville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anindya Kumar Sen | 7113932658 | 2 |
News Archive
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today the presentation of new preclinical data for CYC065, a novel, orally-available, cell cycle kinase inhibitor. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
Vampire bats could hold the key to new treatments for a range of serious medical problems, but researchers have hit a snag accessing the specimens needed to advance their work.
Managing lifestyle factors such as hearing loss, smoking, hypertension and depression could prevent one-third of the world's dementia cases, according to a report by the first Lancet Commission on Dementia Prevention and Care.
Medical diagnostics company Biomoda, Inc. is taking preliminary steps to launch multisite Phase III clinical trials of its in-vitro diagnostic for early-stage lung cancer, trademarked under the name CyPath®.
Protego Medical Pty Ltd, an early stage medical technology company developing a medical device for sternal protection during cardiac surgery, was launched today with AU$2M start-up financing from Australia's Medical Research Commercialisation Fund (MRCF). At the same time, the Company announced the appointment of Pablo Solis as CEO.
› Verified 6 days ago
| Entity Name | Anindya Kumar Sen |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689877078 PECOS PAC ID: 7113932658 Enrollment ID: O20060220000494 |
News Archive
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today the presentation of new preclinical data for CYC065, a novel, orally-available, cell cycle kinase inhibitor. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
Vampire bats could hold the key to new treatments for a range of serious medical problems, but researchers have hit a snag accessing the specimens needed to advance their work.
Managing lifestyle factors such as hearing loss, smoking, hypertension and depression could prevent one-third of the world's dementia cases, according to a report by the first Lancet Commission on Dementia Prevention and Care.
Medical diagnostics company Biomoda, Inc. is taking preliminary steps to launch multisite Phase III clinical trials of its in-vitro diagnostic for early-stage lung cancer, trademarked under the name CyPath®.
Protego Medical Pty Ltd, an early stage medical technology company developing a medical device for sternal protection during cardiac surgery, was launched today with AU$2M start-up financing from Australia's Medical Research Commercialisation Fund (MRCF). At the same time, the Company announced the appointment of Pablo Solis as CEO.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anindya Kumar Sen, MD FACP 1406 Tusculum Blvd, Suite 2000, Greeneville, TN 37745-4332 Ph: (423) 787-7080 | Anindya Kumar Sen, MD FACP 1406 Tusculum Blvd, Suite 2000, Greeneville, TN 37745-4332 Ph: (423) 787-7080 |
News Archive
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today the presentation of new preclinical data for CYC065, a novel, orally-available, cell cycle kinase inhibitor. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
Vampire bats could hold the key to new treatments for a range of serious medical problems, but researchers have hit a snag accessing the specimens needed to advance their work.
Managing lifestyle factors such as hearing loss, smoking, hypertension and depression could prevent one-third of the world's dementia cases, according to a report by the first Lancet Commission on Dementia Prevention and Care.
Medical diagnostics company Biomoda, Inc. is taking preliminary steps to launch multisite Phase III clinical trials of its in-vitro diagnostic for early-stage lung cancer, trademarked under the name CyPath®.
Protego Medical Pty Ltd, an early stage medical technology company developing a medical device for sternal protection during cardiac surgery, was launched today with AU$2M start-up financing from Australia's Medical Research Commercialisation Fund (MRCF). At the same time, the Company announced the appointment of Pablo Solis as CEO.
› Verified 6 days ago
Robert W. Locklear, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 895 E Andrew Johnson Hwy, Greeneville, TN 37745 Phone: 423-639-3330 Fax: 423-639-3342 | |
Maynard W Austin, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1404 Tusculum Blvd, Laughlin Mob, Suite 3100, Greeneville, TN 37745 Phone: 423-638-4114 | |
Muhammad M. Akmal, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 401 Takoma Ave, Greeneville, TN 37743 Phone: 423-278-1743 Fax: 423-278-1930 | |
Dr. Hiren B Patel, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1420 Tusculum Blvd, Greeneville, TN 37745 Phone: 423-783-6400 | |
Dr. Isioma Aninyei, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 401 Takoma Ave, Greeneville, TN 37743 Phone: 828-687-5616 Fax: 828-650-8076 | |
Kimi Hmar Zook, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 810 W Church St, Greeneville, TN 37745 Phone: 423-798-1749 Fax: 423-798-1755 | |
Thomas F Beckner Iii, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1404 Tusculum Blvd, Laughlin Mob, Suite 3100, Greeneville, TN 37745 Phone: 423-638-4114 |